The fight to understand autism is more vital—and complex—than ever before. As research advances and debates intensify, staying informed about key developments and upcoming discussions is essential for anyone invested in autism science. And here’s where it gets truly fascinating: the upcoming 13th Day of Learning promises to shed fresh light on crucial topics, featuring leading experts and groundbreaking insights.
Mark your calendars: the 13th Day of Learning is scheduled for March 26, 2026, and will be held in person at the elegant location of 583 Park Avenue in New York City. This event offers a unique opportunity for professionals, researchers, and interested community members to gather, share ideas, and explore the latest in autism science.
What can attendees expect? The event will showcase a lineup of compelling presentations:
- Josh Gordon from Columbia University and the National Institutes of Health (NIH) will delve into how the landscape of autism research is evolving, highlighting new directions and priorities.
- Helen Tager-Flusberg from Boston University’s Coalition for Autism Scientists will speak out about the challenges and opportunities faced by scientists working in this field, emphasizing advocacy and transparency.
- David Mandell from the University of Pennsylvania will explore the optimistic potential behind federal studies like the Autism and Developmental Studies Initiative (ADSI), aiming to improve outcomes through targeted research.
- John Spiro from the Simons Foundation will discuss efforts to identify and confirm new autism subtypes, providing a more nuanced understanding of the spectrum.
- Stephan Sanders of Oxford University and UCSF will present on the prospects of developing genetic-based medicines, a rapidly progressing area promising personalized treatments.
- Diana Schendel from Drexel University will shed light on how family recurrence patterns extend beyond immediate relatives, which has important implications for genetic counseling and early detection.
Reflecting on the achievements of the last event, the 12th Day of Learning featured remarkable sessions such as:
- Dr. Allyson Berent from Angelman Syndrome Therapeutics, who discussed gene editing and therapies tailored for genetically-defined autism forms.
- Dr. Robert Schultz at the University of Pennsylvania, who examined how artificial intelligence tools are transforming our ability to characterize autism.
- Dr. David Amaral of UC Davis, emphasizing the vital role families play in autism research, especially through studies involving post-mortem brain tissue.
- Dr. Rebeca Levy from Stanford University, introducing innovative models like organoids and assembloids for personalized autism treatments.
- Dr. Elena Tenenbaum at Duke University, demonstrating how AI can deepen our understanding of early developmental stages in infants.
- Dr. Heather Nuske from the University of Pennsylvania, showcasing wearables designed to help reduce severe behaviors in children with profound autism.
While progress might seem steady, the debates surrounding autism research—especially regarding the best paths forward—are often fierce. Some advocates push for rapid technological innovation, while others emphasize ethical considerations and inclusivity. The question remains: how can we balance innovation with compassion? As new discoveries emerge, the controversy is not just about science—it's about how we understand, support, and empower those on the spectrum.
Are you ready to join the conversation and explore these vital issues? What's your take on the future of autism research—are we on the right track, or is there more we should challenge? Share your thoughts below and be part of shaping the ongoing dialogue.
